Healthcare Market Research Reports

More than 6,000 molecules are currently in clinical development across the pharmaceutical research and development (R&D) landscape, with more than 11,000 in the preclinical phase. The industry is witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across...

Digital biomarkers play a crucial role in early disease detection and prevention; data-driven insights generated by wearable support early diagnosis, real-time monitoring of patient health, precise healthcare delivery, remote patient monitoring, and advanced R&D effort in the treatment of neurodegenerative conditions. While innovation focuses on th...

Predictive genetic testing (PGT) comprises analysis of genes, the whole genome, or exomes to predict the risk of a wide range of disorders. It can have long-term implications in preventive healthcare practices, including delayed onset of disease, treatment management, pharmacogenomics, and general wellness. One outcome of the COVID-19 pandemic has ...

The skyrocketing volume of medical imaging data and need to better manage medical images is becoming imperative for healthcare providers. The collaborative HIMSS-SIIM Enterprise Imaging Workgroup de?nes enterprise imaging as “a set of strategies, initiatives, and work?ows implemented across a healthcare enterprise to consistently and optimally ca...